![]() |
市場調查報告書
商品編碼
2035235
穿戴式醫療設備市場預測至2034年-全球設備類型、產品類型、等級、組件、應用、最終用戶、分銷管道和區域分析Wearable Medical Devices Market Forecasts to 2034 - Global Analysis By Device Type, Product Type, Grade, Component, Application, End User, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球穿戴式醫療設備市場規模將達到 699 億美元,並在預測期內以 18.3% 的複合年成長率成長,到 2034 年將達到 2,684 億美元。
穿戴式醫療設備是指佩戴在身上的電子設備,用於持續或間歇性地監測生理參數、追蹤健康指標並實現疾病的早期檢測。這個快速發展的市場包括具備心電圖 (ECG) 功能的智慧型手錶、連續血糖監測儀、用於藥物輸送的穿戴式貼片以及可將患者數據直接傳輸給醫療服務提供者的遠端監測系統。微型感測器、先進電池技術和雲端連接的融合正在改變醫療保健的提供方式,使其從間歇性的門診就診模式轉向持續的、數據驅動的護理模式。
全球慢性病盛行率不斷上升
糖尿病、心血管疾病、高血壓和呼吸系統疾病的全球負擔持續加重,迫切需要傳統臨床環境以外的持續監測解決方案。穿戴式裝置使患者能夠即時追蹤生命徵象、藥物依從性和生活方式因素,從而實現主動疾病管理而非被動危機干預。醫療保健系統正努力應對不斷上漲的慢性病成本,並日益認知到穿戴式裝置作為一種經濟有效的工具在預防患者再次入院和急診就診方面的重要性。隨著全球人口老化,這種需求進一步加劇,因為獨立生活的老年人需要遠端監測解決方案,既能提供安全保障,又能進行臨床監測,而無需入住養老機構。
對資料隱私和安全的擔憂
穿戴式裝置收集的敏感健康資訊不斷受到網路攻擊、未授權存取以及分散的裝置生態系統中資料保護協定不足的威脅。如果患者的生理數據如何儲存、共用或可能被第三方用於商業用途尚不明確,他們仍然對使用連網醫療穿戴裝置持謹慎態度。同樣,如果沒有明確的責任框架或檢驗的安全標準,醫療服務提供者也對將設備產生的資料整合到電子健康記錄 (EHR) 中持謹慎態度。此外,由於製造商必須在保持設備功能和用戶體驗流暢性的同時,滿足有關資料加密、資料外洩通知和患者同意等方面的各種要求,因此跨多個司法管轄區的合規性問題也增加了複雜性。
遠端醫療與人工智慧診斷的融合
虛擬醫療平台的快速發展為穿戴式裝置提供了巨大的機遇,使其能夠作為資料來源支援人工智慧驅動的臨床決策。來自穿戴式裝置的即時病患資料流使醫生能夠進行更精準的遠距醫療,並根據實際的生理趨勢而非病患的記憶來制定個人化的治療方案。分析持續穿戴式資料的機器學習演算法能夠偵測到細微的模式,這些模式預示著疾病的早期發作、藥物依從性差或健康狀況即將惡化,甚至在症狀變得嚴重之前就能發現這些跡象。這種整合透過預防性干預措施改善了患者的治療效果,同時降低了醫療成本,使穿戴式裝置成為現代以金額為準的醫療服務模式的重要組成部分。
來自大型家電公司的激烈競爭
擁有龐大研發預算和成熟分銷網路的科技巨頭對穿戴式設備領域的傳統醫療設備製造商構成了重大威脅。面向一般消費者的智慧型手錶和健身追蹤器正日益融入醫療級功能,例如心房顫動檢測、血氧監測和跌倒偵測,模糊了健康設備和受監管醫療設備之間的界線。這些新參與企業擁有品牌忠誠度、龐大用戶群和快速創新週期等優勢,而傳統醫療設備製造商難以與之匹敵。隨著消費性電子產品製造商利用規模經濟以極具競爭力的價格提供功能豐富的設備,曾經專業化的醫療技術面臨著商品化的風險,這將給中小規模的醫療穿戴式裝置製造商的利潤率帶來壓力。
新冠疫情大大加速了醫療穿戴裝置的普及,醫療系統紛紛尋求遠端監測解決方案,以最大限度地減少病毒暴露風險,並確保醫院能夠收治重症患者。新冠復健患者在家中使用穿戴式裝置監測血氧飽和度、心率變異性和呼吸功能,減輕了前往擁擠診所就診的負擔。這場危機鞏固了遠端醫療在先前持懷疑態度的患者群體和醫療服務提供者中的應用,並創造了對整合式遠距監測解決方案的持續需求。儘管供應鏈中斷最初限制了設備的供應,但隨後製造流程的改進和對醫療技術基礎設施投資的增加,為疫情後市場的持續成長奠定了基礎。
在預測期內,遠端患者監護領域預計將佔據最大的市場佔有率。
在預測期內,遠端患者監護領域預計將佔據最大的市場佔有率。這主要得益於醫療服務模式從以服務量而非治療效果為以金額為準的補償模式的轉變。該應用程式能夠持續追蹤慢性病患者在臨床環境之外的健康狀況,並將血壓、血糖值、心率和呼吸功能等數據直接髮送給醫療團隊。醫院可以透過在出院後這段脆弱時期對患者進行監測來降低再入院風險,而保險公司則可以從急診就診率和住院費用的降低中獲益。老年人希望居住在熟悉的環境中,這項需求也進一步推動了遠距監護的普及,因為遠距監護無需患者入住醫療機構即可讓家人和醫療服務提供者了解患者的臨床狀況。
在預測期內,「居家醫療」細分市場預計將呈現最高的複合年成長率。
在預測期內,「居家醫療」領域預計將呈現最高的成長率,這反映出醫療保健服務模式正從以醫院為中心向以居家照護的照護模式發生廣泛轉變。穿戴式裝置使術後復健患者、慢性病管理患者或需要安寧療護的患者無需住院即可接受臨床管理,從而降低醫療成本,同時提高患者的舒適度和滿意度。科技進步使得家用醫療穿戴式裝置越來越容易使用,其直覺的智慧型手機介面和自動資料傳輸功能幾乎無需任何技術知識即可操作。居家醫院計畫、保險覆蓋的遠端監控代碼以及人口老化加劇(人們強烈希望在熟悉的家中而非醫療機構接受護理)等因素進一步加速了該領域的成長。
在預測期內,北美地區預計將佔據最大的市場佔有率,這得益於其先進的醫療基礎設施、較高的技術普及率以及對遠端監測服務有利的報銷政策。該地區醫療設備產業高度集中,包括眾多穿戴式技術創新企業,正推動產品的持續研發和臨床檢驗研究。智慧型手機的高普及率和強大的寬頻連接使得設備能夠在都市區和郊區人口中無縫整合。各大醫療機構正在系統性地將穿戴式裝置數據整合到電子健康記錄和臨床工作流程中,以建立永續的醫療模式。強大的智慧財產權保護以及美國食品藥物管理局(FDA)簡化的數位健康技術監管流程預計將在整個預測期內進一步鞏固北美市場的領先地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於龐大的患者群體、快速現代化的醫療保健系統以及智慧型手機在以往服務不足地區的廣泛普及。中國、印度、日本和韓國等國家由於人口老化,慢性病負擔日益加重,因此迫切需要經濟高效的遠端監測解決方案來擴大臨床覆蓋範圍。政府的數位健康舉措和對遠端醫療基礎設施的投資,創造了鼓勵穿戴式裝置普及的法規環境。該地區強大的電子製造業生態系統,使得本地生產的設備價格具有競爭力,而不斷成長的中產階級可支配收入也擴大了目標市場。隨著亞太地區醫療保健數位化進程的加速,該地區正崛起為穿戴式醫療設備成長最快的市場。
According to Stratistics MRC, the Global Wearable Medical Devices Market is accounted for $69.9 billion in 2026 and is expected to reach $268.4 billion by 2034 growing at a CAGR of 18.3% during the forecast period. Wearable medical devices are electronic instruments worn on the body that continuously or intermittently monitor physiological parameters, track health metrics, and enable early detection of medical conditions. This rapidly evolving market includes smartwatches with ECG capabilities, continuous glucose monitors, wearable patches for drug delivery, and remote monitoring systems that transmit patient data directly to healthcare providers. The convergence of miniaturized sensors, advanced battery technology, and cloud connectivity is transforming how healthcare is delivered, shifting from episodic clinical visits to continuous, data-driven care models.
Rising prevalence of chronic diseases worldwide
The global burden of diabetes, cardiovascular disorders, hypertension, and respiratory conditions continues to escalate, creating urgent demand for continuous monitoring solutions outside traditional clinical settings. Wearable devices enable patients to track vital signs, medication adherence, and lifestyle factors in real time, empowering proactive disease management rather than reactive crisis intervention. Healthcare systems burdened by rising chronic care costs increasingly recognize wearables as cost-effective tools for preventing hospital readmissions and emergency room visits. The aging global population further amplifies this need, as older adults living independently require remote monitoring solutions that provide both safety and clinical oversight without institutionalization.
Data privacy and security concerns
Sensitive health information collected by wearable devices faces continuous threats from cyberattacks, unauthorized access, and inadequate data protection protocols across fragmented device ecosystems. Patients remain hesitant to adopt connected medical wearables when uncertain about how their physiological data is stored, shared, or potentially monetized by third parties. Healthcare providers similarly exercise caution when integrating device-generated data into electronic health records without clear liability frameworks and validated security standards. Regulatory compliance across multiple jurisdictions adds complexity, as manufacturers must navigate varying requirements for data encryption, breach notification, and patient consent while maintaining seamless device functionality and user experience.
Integration with telemedicine and AI diagnostics
The rapid expansion of virtual care platforms creates substantial opportunities for wearable devices to serve as data sources powering AI-driven clinical decision support. Real-time patient data streams from wearables enable physicians to conduct more informed remote consultations, adjusting treatment plans based on actual physiological trends rather than patient recollection. Machine learning algorithms analyzing continuous wearable data can detect subtle patterns indicating early disease onset, medication non-adherence, or impending health deterioration before symptoms become severe. This integration reduces healthcare costs through preventive intervention while improving patient outcomes, making wearables indispensable components of modern, value-based healthcare delivery models.
Intense competition from consumer electronics giants
Major technology companies with substantial research budgets and established distribution networks pose significant threats to traditional medical device manufacturers in the wearable space. Consumer-focused smartwatches and fitness trackers increasingly incorporate medical-grade features such as atrial fibrillation detection, blood oxygen monitoring, and fall detection, blurring boundaries between wellness devices and regulated medical products. These entrants benefit from brand loyalty, massive user bases, and rapid innovation cycles that traditional medical device companies struggle to match. Smaller medical wearable manufacturers face margin pressure as consumer electronics companies leverage scale to offer feature-rich devices at competitive price points, potentially commoditizing previously specialized medical technologies.
The COVID-19 pandemic dramatically accelerated wearable medical device adoption as healthcare systems sought remote monitoring solutions to minimize viral exposure and preserve hospital capacity for critical cases. Patients recovering from COVID-19 utilized wearables to track oxygen saturation, heart rate variability, and respiratory function from home, reducing follow-up visit burdens on overwhelmed clinics. The crisis normalized virtual care across previously skeptical patient populations and provider organizations, creating lasting demand for integrated remote monitoring solutions. Supply chain disruptions initially constrained device availability, but subsequent manufacturing adaptations and increased investment in health technology infrastructure positioned the market for sustained post-pandemic growth.
The Remote Patient Monitoring segment is expected to be the largest during the forecast period
The Remote Patient Monitoring segment is expected to account for the largest market share during the forecast period, driven by healthcare system transitions toward value-based reimbursement models that reward outcomes rather than service volume. This application enables continuous tracking of patients with chronic conditions outside clinical settings, transmitting data on blood pressure, glucose levels, heart rhythm, and respiratory function directly to care teams. Hospitals reduce readmission penalties by monitoring discharged patients during vulnerable post-discharge periods, while payers benefit from reduced emergency department utilization and hospitalization costs. The aging population's desire to age in place further fuels adoption, as remote monitoring provides families and providers with clinical visibility without institutional care requirements.
The Home Care Settings segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Home Care Settings segment is predicted to witness the highest growth rate, reflecting the broader healthcare shift from hospital-centric to home-based care delivery models. Wearable devices enable patients recovering from surgery, managing chronic conditions, or requiring palliative support to receive clinical oversight without institutional admission, reducing healthcare costs while improving patient comfort and satisfaction. Technological advancements have made home-use medical wearables increasingly user-friendly, with intuitive smartphone interfaces and automated data transmission requiring minimal technical literacy. The segment's growth is further accelerated by hospital-at-home programs, reimbursable remote monitoring codes, and aging populations expressing strong preference for receiving care in familiar home environments rather than clinical facilities.
During the forecast period, the North America region is expected to hold the largest market share, supported by advanced healthcare infrastructure, high technology adoption rates, and favorable reimbursement policies for remote monitoring services. The region's concentrated medical device industry, including numerous wearable technology innovators, drives continuous product advancement and clinical validation studies. Widespread smartphone penetration and robust broadband connectivity enable seamless device integration across urban and suburban populations. Major health systems have systematically incorporated wearable data into electronic health records and clinical workflows, creating sustainable care models. Strong intellectual property protections and streamlined FDA regulatory pathways for digital health technologies further reinforce North America's market leadership throughout the forecast period.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by large patient populations, rapidly modernizing healthcare systems, and increasing smartphone penetration across previously underserved communities. Countries including China, India, Japan, and South Korea face escalating chronic disease burdens alongside aging demographics, creating urgent demand for cost-effective remote monitoring solutions that extend clinical reach. Government digital health initiatives and telemedicine infrastructure investments provide supportive regulatory environments for wearable device deployment. The region's robust electronics manufacturing ecosystem enables competitive pricing for locally produced devices, while rising middle-class disposable incomes expand addressable markets. As healthcare digitization accelerates across Asia Pacific, the region emerges as the fastest-growing market for wearable medical devices.
Key players in the market
Some of the key players in Wearable Medical Devices Market include Apple Inc., Samsung Electronics Co. Ltd., Fitbit Inc., Garmin Ltd., Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Omron Corporation, Abbott Laboratories, Dexcom Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, Polar Electro Oy, Withings SA and Masimo Corporation.
In April 2026, Google teased a new Fitbit 2026 Band via performance advisor Steph Curry; the device is a screenless, woven strap focused on recovery, strain, and 24/7 biometrics, moving Fitbit into the high-performance "subscription-based" recovery market.
In September 2025, Apple launched the Apple Watch Series 11, featuring upgraded Vitals sensors and enhanced Sleep Apnea detection algorithms, solidifying its position in the "Consumer-Clinical" bridge market.
In July 2025, Samsung launched the Galaxy Watch8 Series, introducing advanced sleep coaching and fitness tracking powered by "Galaxy AI" for predictive health insights.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.